1. Home
  2. EYPT vs PSFE Comparison

EYPT vs PSFE Comparison

Compare EYPT & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • PSFE
  • Stock Information
  • Founded
  • EYPT 1987
  • PSFE 1996
  • Country
  • EYPT United States
  • PSFE United Kingdom
  • Employees
  • EYPT N/A
  • PSFE N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • PSFE Business Services
  • Sector
  • EYPT Industrials
  • PSFE Consumer Discretionary
  • Exchange
  • EYPT Nasdaq
  • PSFE Nasdaq
  • Market Cap
  • EYPT 741.0M
  • PSFE 765.0M
  • IPO Year
  • EYPT 2005
  • PSFE N/A
  • Fundamental
  • Price
  • EYPT $14.00
  • PSFE $12.46
  • Analyst Decision
  • EYPT Strong Buy
  • PSFE Sell
  • Analyst Count
  • EYPT 6
  • PSFE 4
  • Target Price
  • EYPT $25.83
  • PSFE $17.38
  • AVG Volume (30 Days)
  • EYPT 1.1M
  • PSFE 237.1K
  • Earning Date
  • EYPT 11-06-2025
  • PSFE 11-12-2025
  • Dividend Yield
  • EYPT N/A
  • PSFE N/A
  • EPS Growth
  • EYPT N/A
  • PSFE N/A
  • EPS
  • EYPT N/A
  • PSFE N/A
  • Revenue
  • EYPT $51,898,000.00
  • PSFE $1,676,391,000.00
  • Revenue This Year
  • EYPT N/A
  • PSFE $3.18
  • Revenue Next Year
  • EYPT N/A
  • PSFE $7.05
  • P/E Ratio
  • EYPT N/A
  • PSFE N/A
  • Revenue Growth
  • EYPT 2.99
  • PSFE 0.47
  • 52 Week Low
  • EYPT $3.91
  • PSFE $10.63
  • 52 Week High
  • EYPT $14.91
  • PSFE $26.25
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 58.99
  • PSFE 37.92
  • Support Level
  • EYPT $13.00
  • PSFE $12.65
  • Resistance Level
  • EYPT $14.04
  • PSFE $13.56
  • Average True Range (ATR)
  • EYPT 0.93
  • PSFE 0.41
  • MACD
  • EYPT -0.08
  • PSFE -0.09
  • Stochastic Oscillator
  • EYPT 62.87
  • PSFE 12.82

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About PSFE Paysafe Limited

Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.

Share on Social Networks: